Kevin Richardson, CEO of SANUWAVE Health, Inc., Discusses Positive Close to 2017 and Upcoming Events in 2018 on Uptick Newswire’s “Stock Day” with Everett Jolly

PHOENIX, April 11, 2018 -- SANUWAVE Health, Inc. (OTCQB: SNWV) ("the Company"), today announced CEO Kevin Richardson’s return to Uptick Newswire’s “Stock Day” podcast to review achievements in 2018 and positive momentum moving forward. 

“It is a pleasure to have Kevin Richardson of SANUWAVE Health back on the show.  Since we last spoke in February, the stock price has increased from $0.21 to $0.58,” said Jolly.  “The Company has also increased visibility through conferences, and its blog ‘Shock This.’”

In order to realize its high growth opportunity, the Company established a two-pronged development infrastructure consisting of equipment financing and increasing product reach through strategic partnering.  “The Company has partnered with Premier Shockwave which has increased our reach to Veteran’s Administration (VA), Indian Health Services (IHS) and Tribally operated healthcare services, and US Military facilities/bases (MTFs),” said Richardson.  “Internationally, we are making significant inroads and our product’s impact has afforded us a featured spot at the European Wound Management Association (EWMA), the largest wound care convention in Europe.

“Additionally, our goal of financing without diluting the stock has been successful,” Richardson continued.  “We have a favorable line of credit that will allow us to produce our dermaPACE at a rate congruent with our growth in sales and increased international recognition.”

In addition to its four podium presentations at EWMA, SANUWAVE Health will be exhibiting at the Symposium on Advanced Wound Care (SAWC) Booth 108 and publishes expert interviews on its blog, Shock This.

To listen to the full interview please click here to the following link:  https://upticknewswire.com/featured-interview-ceo-kevin-richardson-of-sanuwave-health-inc-otcqb-snwv-3/

Visit the Company’s blog ‘Shock This’ at: Shock This

For more information on the conferences SANUWAVE will be attending click the following links:

Exhibit at SAWC

Podium Presentations at EWMA

About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. (OTCQB:SNWV) (www.sanuwave.com) is a shock wave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. SANUWAVE’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses, producing new vascularization and microcirculatory improvement, which helps restore the body’s normal healing processes and regeneration. SANUWAVE applies its patented PACE technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Its lead product candidate for the global wound care market, dermaPACE^®, is US FDA cleared for the treatment of Diabetic Foot Ulcers.  The device is also CE Marked throughout Europe and has device license approval for the treatment of the skin and subcutaneous soft tissue in Canada, South Korea, Australia and New Zealand. SANUWAVE researches, designs, manufactures, markets and services its products worldwide, and believes it has demonstrated that its technology is safe and effective in stimulating healing in chronic conditions of the foot (plantar fasciitis) and the elbow (lateral epicondylitis) through its U.S. Class III PMA approved OssaTron^® device, as well as stimulating bone and chronic tendonitis regeneration in the musculoskeletal environment through the utilization of its OssaTron, Evotron^® and orthoPACE^® devices in Europe, Asia and Asia/Pacific. In addition, there are license/partnership opportunities for SANUWAVE’s shock wave technology for non-medical uses, including energy, water, food and industrial markets.

Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future business development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company’s product candidates and products, unproven pre-clinical and clinical development activities, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.

For additional information about the Company, visit www.sanuwave.com.

Contact:
Millennium Park Capital LLC
Christopher Wynne
312-724-7845
[email protected]

SANUWAVE Health, Inc.
Kevin Richardson II
Chairman of the Board
978-922-2447
[email protected]

About Uptick Newswire and the “Stock Day” Podcast
Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network “Stock Day” Podcast. The Uptick Network “Stock Day” Podcast is an extension of Uptick Newswire and has recently launched the Video Interview Studio located in Phoenix, Arizona.

Source: Uptick Newswire

Investors Hangout is a proud sponsor of Stock Day and Uptick Newswire encourages listeners to visit SANUWAVE Health, Inc., message board on: https://investorshangout.com/